Alzamend Neuro Inc Strategic Asset Allocation Index
Alzamend Neuro Inc strategic asset allocation index. Alzamend Neuro Inc (ALZN) has a Strategic Asset Allocation Index of 2.6% as of April 2023. Strategic assets (PP&E of $79.84K plus long-term investments of $-) total $79.84K, measured against net assets of $3.05 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Alzamend Neuro Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Alzamend Neuro Inc (2022–2023)
Strategic asset allocation index of Alzamend Neuro Inc from 2022 to 2023. This chart shows how Alzamend Neuro Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2022 to 2023. As of April 2023, the index stands at 2.6%, representing strategic assets of $79.84K against net assets of $3.05 Million USD. Check ALZN goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Alzamend Neuro Inc Strategic Asset Allocation Index by Year (2022–2023)
Alzamend Neuro Inc strategic asset allocation index by year from 2022 to 2023. The table below presents the year-by-year Strategic Asset Allocation Index for Alzamend Neuro Inc from 2022 to 2023, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ALZN company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 2.6% | $79.84K | $79.84K | $- | $3.05 Million | ▲ +1.9 pp |
| 2022 | 0.8% | $102.91K | $102.91K | $- | $13.35 Million | — |